TXN
46
-2
CB
62
-5
RCL
58
-3
USB
55
-3
AMZN
53
-4
LEG
55
2
KIM
54
-2
FITB
59
-6
BWA
48
-5
RRC
65
-3
AON
63
-2
FOXA
59
-3
MTB
63
-5
PH
60
-4
TSN
48
-2
ROP
38
-4
DE
42
-3
CHD
32
-3
RHI
34
-3
DG
63
-2
TXN
46
-2
CB
62
-5
RCL
58
-3
USB
55
-3
AMZN
53
-4
LEG
55
2
KIM
54
-2
FITB
59
-6
BWA
48
-5
RRC
65
-3
AON
63
-2
FOXA
59
-3
MTB
63
-5
PH
60
-4
TSN
48
-2
ROP
38
-4
DE
42
-3
CHD
32
-3
RHI
34
-3
DG
63
-2
Financhill
Back

Berkshire Hathaway, Inc. Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Sell
49

BRK.A
Berkshire Hathaway, Inc.

Last Price:
$753,731.01
Seasonality Move:
6.5%
Sell
26

ORKA
Oruka Therapeutics, Inc.

Last Price:
$30.39
Seasonality Move:
-9.32%
Sell
49
Berkshire Hathaway, Inc. (BRK.A) is a Sell

Is Berkshire Hathaway, Inc. a Buy, Sell or Hold?

  • The current Berkshire Hathaway, Inc. [BRK.A] share price is $754,800.00. The Score for BRK.A is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • BRK.A is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Oruka Therapeutics, Inc. (ORKA) is a Sell

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $30.31. The Score for ORKA is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • ORKA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BRK.A Stock Price Chart

What is Berkshire Hathaway, Inc.'s stock price today?

  • The Berkshire Hathaway, Inc. share price today is $754,800.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BRK.A is experiencing slight selling pressure.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $30.31
    The current trend is moderately bullish and ORKA is experiencing slight buying pressure.

BRK.A Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 674.89 Buy
Relative Strength Index (14 RSI): 53.21 Buy
Chaikin Money Flow: -142 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (753006.23 - 753022.23) Buy
Bollinger Bands (100): (743148.84 - 743174.84) Buy

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.57 Buy
Relative Strength Index (14 RSI): 51.81 Buy
Chaikin Money Flow: 234570 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29 - 31.58) Buy
Bollinger Bands (100): (16.97 - 29.87) Buy

BRK.A Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 750826.34 Buy
20-day SMA: 750156.48 Buy
50-day SMA: 747185.3 Buy
200-day SMA: 747227.11 Buy
8-day EMA: 752201.74 Buy
20-day EMA: 751506.92 Buy
50-day EMA: 748775.57 Buy
200-day EMA: 736008.79 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.21 Sell
20-day SMA: 30.53 Sell
50-day SMA: 28.99 Buy
200-day SMA: 17.48 Buy
8-day EMA: 30.57 Sell
20-day EMA: 30.26 Buy
50-day EMA: 28.26 Buy
200-day EMA: 21.62 Buy

Berkshire Hathaway, Inc. Earnings Growth & BRK.A Earnings Dates

  • Analysts estimate an earnings increase this quarter of $299.76 per share, a decrease next quarter of $0.00 per share, an increase this year of $3,470.08 per share, and a decrease next year of $2,259.18 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.32 per share, and a decrease next year of $0.42 per share.

Berkshire Hathaway, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):